The forecasted mortality rate for pneumonia among men in the US shows a steady decline from 13.3 deaths per 100,000 men in 2024 to 12.1 deaths in 2028. This consistent reduction suggests a year-on-year decrease in pneumonia-related mortality.
- Year-on-year variations indicate a decline of approximately 2-2.5% annually over the forecasted period.
- The compound annual growth rate (CAGR) from 2024 to 2028 forecasts an average annual decrease, highlighting the improvement in managing and treating pneumonia.
Future trends to watch include advancements in medical technology, the development of new vaccines, and public health initiatives, which could further accelerate this declining trend in pneumonia mortality rates among US men.
